» Articles » PMID: 8188077

Decreased E-cadherin Expression in Endometrial Carcinoma is Associated with Tumor Dedifferentiation and Deep Myometrial Invasion

Overview
Journal Gynecol Oncol
Date 1994 May 1
PMID 8188077
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Decreased E-cadherin expression in tumor cells has been suggested to promote tumor invasiveness. We examined E-cadherin expression in 30 cases of endometrial carcinoma by immunohistochemistry using a monoclonal antibody to E-cadherin and investigated its correlation with other histopathologic features of the tumor. We observed that: (1) E-cadherin expression decreased with loss of differentiation (P < 0.05); (2) E-cadherin expression was inversely correlated with depth of myometrial invasion (P < 0.05); (3) decreased E-cadherin expression was correlated with paraaortic node metastasis (P < 0.01); and (4) multivariate analysis comparing the depth of myometrial invasion to the pattern of E-cadherin expression, histologic grade, nuclear grade, and lymph-vascular space invasion showed that the depth of myometrial invasion was most strongly correlated with decreased E-cadherin expression (P < 0.005). These findings seem to be consistent with the concept that the dissociation of cancer cells due to decreased expression of E-cadherin facilitates invasion of tumor cells.

Citing Articles

A Retrospective Study on the Expression of E-Cadherin in Endometrial Carcinoma.

Jayaraman M, En N, V L, Harikrishnan V Cureus. 2024; 16(10):e70767.

PMID: 39493171 PMC: 11531303. DOI: 10.7759/cureus.70767.


Expression of E-cadherin in Hyperplastic Endometrium: A Retrospective Analysis.

Jayaraman M, En N, Harikrishnan V Cureus. 2024; 16(7):e65225.

PMID: 39184723 PMC: 11341771. DOI: 10.7759/cureus.65225.


RON, ROR1 and SUSD2 expression in tissues of endometrial carcinoma patients. Clinicopathological and prognostic implications.

Abdelbary A, Kaf R, Lashin M, Alattar A, Elsayed D, Amin A Contemp Oncol (Pozn). 2022; 26(2):109-122.

PMID: 35903204 PMC: 9319185. DOI: 10.5114/wo.2022.118245.


RON Mediates Tumor-Promoting Effects in Endometrial Adenocarcinoma.

Yu Q, Wang J, Li T, Xu X, Guo X, Ding S Biomed Res Int. 2021; 2021:2282916.

PMID: 34712728 PMC: 8548096. DOI: 10.1155/2021/2282916.


Direct Cell⁻Cell Interactions in the Endometrium and in Endometrial Pathophysiology.

Grund S, Grummer R Int J Mol Sci. 2018; 19(8).

PMID: 30061539 PMC: 6121364. DOI: 10.3390/ijms19082227.